56 related articles for article (PubMed ID: 8558922)
1. Mastocytosis.
Brockow K; Metcalfe DD
Chem Immunol Allergy; 2010; 95():110-124. PubMed ID: 20519885
[TBL] [Abstract][Full Text] [Related]
2. Metaplastic transformation of urinary bladder epithelium: effect on mast cell recruitment, distribution, and phenotype expression.
Aldenborg F; Peeker R; Fall M; Olofsson A; Enerbäck L
Am J Pathol; 1998 Jul; 153(1):149-57. PubMed ID: 9665475
[TBL] [Abstract][Full Text] [Related]
3. Modern Imaging Technologies of Mast Cells for Biology and Medicine (Review).
Grigorev IP; Korzhevskii DE
Sovrem Tekhnologii Med; 2021; 13(4):93-107. PubMed ID: 34603768
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic modulation of KIT ligand in melanocytic disorders with implications for mast cell diseases.
Sevilla A; Grichnik J
Exp Dermatol; 2024 May; 33(5):e15091. PubMed ID: 38711220
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic significance of mast cell markers in HIV/AIDS: Current insights and future directions.
Obeagu EI
Medicine (Baltimore); 2024 May; 103(20):e38117. PubMed ID: 38758896
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD117 (c-Kit) on Circulating B Cells in Pediatric Schistosomiasis.
Onkanga IO; Hamilton R; Mwinzi PNM; Schneider T; Ondigo BN; Sang H; Ondari E; Rawago F; Jaoko W; Odiere MR; Ganley-Leal L
Infect Immun; 2022 Aug; 90(8):e0016022. PubMed ID: 35862720
[TBL] [Abstract][Full Text] [Related]
7. CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosis.
Mueller N; Wicklein D; Eisenwort G; Jawhar M; Berger D; Stefanzl G; Greiner G; Boehm A; Kornauth C; Muellauer L; Sehner S; Hoermann G; Sperr WR; Staber PB; Jaeger U; Zuber J; Arock M; Schumacher U; Reiter A; Valent P
Blood; 2018 Nov; 132(18):1936-1950. PubMed ID: 30018080
[TBL] [Abstract][Full Text] [Related]
8. Chronic mast cell leukemia: a novel leukemia-variant with distinct morphological and clinical features.
Valent P; Sotlar K; Sperr WR; Reiter A; Arock M; Horny HP
Leuk Res; 2015 Jan; 39(1):1-5. PubMed ID: 25443885
[TBL] [Abstract][Full Text] [Related]
9. Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal.
Valent P; Sotlar K; Sperr WR; Escribano L; Yavuz S; Reiter A; George TI; Kluin-Nelemans HC; Hermine O; Butterfield JH; Hägglund H; Ustun C; Hornick JL; Triggiani M; Radia D; Akin C; Hartmann K; Gotlib J; Schwartz LB; Verstovsek S; Orfao A; Metcalfe DD; Arock M; Horny HP
Ann Oncol; 2014 Sep; 25(9):1691-1700. PubMed ID: 24675021
[TBL] [Abstract][Full Text] [Related]
10. Tetraspanins in mast cells.
Köberle M; Kaesler S; Kempf W; Wölbing F; Biedermann T
Front Immunol; 2012; 3():106. PubMed ID: 22783251
[TBL] [Abstract][Full Text] [Related]
11. Human and mouse mast cells use the tetraspanin CD9 as an alternate interleukin-16 receptor.
Qi JC; Wang J; Mandadi S; Tanaka K; Roufogalis BD; Madigan MC; Lai K; Yan F; Chong BH; Stevens RL; Krilis SA
Blood; 2006 Jan; 107(1):135-42. PubMed ID: 16144798
[TBL] [Abstract][Full Text] [Related]
12. Synovial mast cell responses during clinical improvement in early rheumatoid arthritis.
Gotis-Graham I; Smith MD; Parker A; McNeil HP
Ann Rheum Dis; 1998 Nov; 57(11):664-71. PubMed ID: 9924208
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and functional characterization of mast cells derived from renal tumor tissues.
Beil WJ; Füreder W; Wiener H; Grossschmidt K; Maier U; Schedle A; Bankl HC; Lechner K; Valent P
Exp Hematol; 1998 Feb; 26(2):158-69. PubMed ID: 9472805
[TBL] [Abstract][Full Text] [Related]
14. Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis.
Valent P; Spanblöchl E; Bankl HC; Sperr WR; Marosi C; Pirc-Danoewinata H; Virgolini I; Eichler HG; Agis H; Sillaber C
Blood; 1994 Dec; 84(12):4322-32. PubMed ID: 7527672
[TBL] [Abstract][Full Text] [Related]
15. The human cardiac mast cell: localization, isolation, phenotype, and functional characterization.
Sperr WR; Bankl HC; Mundigler G; Klappacher G; Grossschmidt K; Agis H; Simon P; Laufer P; Imhof M; Radaszkiewicz T; Glogar D; Lechner K; Valent P
Blood; 1994 Dec; 84(11):3876-84. PubMed ID: 7524750
[TBL] [Abstract][Full Text] [Related]
16. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
17. Mast cell-lineage versus basophil lineage involvement in myeloproliferative and myelodysplastic syndromes: diagnostic role of cell-immunophenotyping.
Agis H; Beil WJ; Bankl HC; Füreder W; Sperr WR; Ghannadan M; Baghestanian M; Sillaber C; Bettelheim P; Lechner K; Valent P
Leuk Lymphoma; 1996 Jul; 22(3-4):187-204. PubMed ID: 8819068
[TBL] [Abstract][Full Text] [Related]
18. A case of malignant mastocytosis with circulating mast cell precursors: biologic and phenotypic characterization of the malignant clone.
Baghestanian M; Bankl Hc; Sillaber C; Beil WJ; Radaszkiewicz T; Füreder W; Preiser J; Vesely M; Schernthaner G; Lechner K; Valent P
Leukemia; 1996 Jan; 10(1):159-66. PubMed ID: 8558922
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
